SMD Pharmacy Ltd 31/07/2019 iXBRL
SMD Pharmacy Ltd 31/07/2019 iXBRL
Company registration number:
11485547
Trading as
SMD Pharmacy Ltd
Unaudited filleted financial statements
SMD PHARMACY LTD
Contents
Statement of financial position
Notes to the financial statements
SMD PHARMACY LTD
STATEMENT OF FINANCIAL POSITION
31 JULY 2019
31/07/19 | |||||
Note | £ | £ | |||
Fixed assets | |||||
Intangible assets | 5 |
|
|||
Tangible assets | 6 |
|
|||
_______ | |||||
|
|||||
Current assets | |||||
Cash at bank and in hand |
|
||||
_______ | |||||
|
|||||
Creditors: amounts falling due | |||||
within one year | 7 |
(
|
|||
_______ | |||||
Net current assets |
|
||||
_______ | |||||
Total assets less current liabilities |
|
||||
Provisions for liabilities |
|
||||
_______ | |||||
Net assets |
|
||||
_______ | |||||
Capital and reserves | |||||
Called up share capital | 8 |
|
|||
Profit and loss account | 9 |
|
|||
_______ | |||||
Shareholders funds |
|
||||
_______ | |||||
Directors responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
14 April 2020
, and are signed on behalf of the board by:
Director
Company registration number:
11485547
SMD PHARMACY LTD
NOTES TO THE FINANCIAL STATEMENTS
PERIOD ENDED 31 JULY 2019
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 96 High Street, Ilfracombe, Devon, EX34 9NH.
Principal activity
The principal activity of the company is providing pharmacy services.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
Judgements and key sources of estimation uncertainty
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
Goodwill
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill | - |
|
|
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery | - | 25% Straight Line | |
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Provisions
Financial instruments
4.
Employee numbers
The average number of persons employed by the company during the period amounted to
1
5.
Intangible assets
Goodwill | Total | ||
£ | £ | ||
Cost | |||
At 26 July 2018 | - | - | |
Additions | 5,000 | 5,000 | |
_______ | _______ | ||
At 31 July 2019 |
|
|
|
_______ | _______ | ||
Amortisation | |||
At 26 July 2018 | - | - | |
Charge for the period |
|
|
|
_______ | _______ | ||
At 31 July 2019 |
|
|
|
_______ | _______ | ||
Carrying amount | |||
At 31 July 2019 |
|
|
|
_______ | _______ | ||
6.
Tangible assets
Plant and machinery | Total | ||
£ | £ | ||
Cost | |||
At 26 July 2018 | - | - | |
Additions | 1,404 | 1,404 | |
_______ | _______ | ||
At 31 July 2019 |
|
|
|
_______ | _______ | ||
Depreciation | |||
At 26 July 2018 | - | - | |
Charge for the year |
|
|
|
_______ | _______ | ||
At 31 July 2019 |
|
|
|
_______ | _______ | ||
Carrying amount | |||
At 31 July 2019 |
|
|
|
_______ | _______ | ||
7.
Creditors: amounts falling due within one year
31/07/19 | |||
£ | |||
Accruals and deferred income |
|
||
Social security and other taxes | 7,672 | ||
Other creditors | 7,332 | ||
_______ | |||
|
|||
_______ | |||
8.
Called up share capital
Shares were allotted, issued and fully paid up during the period.
9.
Reserves
10.
Directors advances, credits and guarantees
During the period the directors entered into the following advances and credits with the company: | ||||
Loans to / (from) directors at 1 August 2018 | Loans to / (from) the directors | Balance at 31 July 2019 | ||
£ | £ | £ | ||
Directors | - |
(
|
(
|
|
_______ | _______ | _______ | ||
Directors' loans are repayable on demand and subject to interest on overdrawn balances at the official rate.